Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
1.
Psychiatry Res Neuroimaging ; 303: 111127, 2020 09 30.
Artigo em Inglês | MEDLINE | ID: mdl-32593950

RESUMO

We sought effective (directional) connectivity parameters associated with response to citalopram in cocaine use disorder (CUD) by conducting a functional magnetic resonance imaging (fMRI) experiment with participants diagnosed with CUD (n = 13) and matched healthy controls (HC; n = 17). CUD participants showed a positive correlation between bilateral DLPFC-to-putamen effective connectivity and treatment effectiveness score. These preliminary results support further investigation of prefrontal-striatal interactions in response to treatment in CUD.


Assuntos
Citalopram/uso terapêutico , Transtornos Relacionados ao Uso de Cocaína/tratamento farmacológico , Corpo Estriado/efeitos dos fármacos , Imageamento por Ressonância Magnética/métodos , Córtex Pré-Frontal/efeitos dos fármacos , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Adulto , Citalopram/farmacologia , Transtornos Relacionados ao Uso de Cocaína/diagnóstico por imagem , Corpo Estriado/diagnóstico por imagem , Feminino , Humanos , Comportamento Impulsivo/efeitos dos fármacos , Comportamento Impulsivo/fisiologia , Masculino , Rede Nervosa/diagnóstico por imagem , Rede Nervosa/efeitos dos fármacos , Córtex Pré-Frontal/diagnóstico por imagem , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Resultado do Tratamento , Adulto Jovem
2.
Acta Psychiatr Scand ; 121(6): 453-61, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20064125

RESUMO

OBJECTIVE: We investigated trait impulsivity in bipolar disorder and antisocial personality disorder (ASPD) with respect to severity and course of illness. METHOD: Subjects included 78 controls, 34 ASPD, 61 bipolar disorder without Axis II disorder, and 24 bipolar disorder with ASPD, by Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (SCID-I and -II). Data were analyzed using general linear model and probit analysis. RESULTS: Barratt Impulsiveness Scale (BIS-11) scores were higher in ASPD (effect sizes 0.5-0.8) or bipolar disorder (effect size 1.45) than in controls. Subjects with both had more suicide attempts and previous episodes than bipolar disorder alone, and more substance-use disorders and suicide attempts than ASPD alone. BIS-11 scores were not related to severity of crimes. CONCLUSION: Impulsivity was higher in bipolar disorder with or without ASPD than in ASPD alone, and higher in ASPD than in controls. Adverse effects of bipolar disorder in ASPD, but not of ASPD in bipolar disorder, were accounted for by increased impulsivity.


Assuntos
Transtorno da Personalidade Antissocial , Transtorno Bipolar , Comportamento Impulsivo , Transtornos Relacionados ao Uso de Substâncias/psicologia , Adulto , Transtorno da Personalidade Antissocial/complicações , Transtorno da Personalidade Antissocial/diagnóstico , Transtorno da Personalidade Antissocial/psicologia , Transtorno da Personalidade Antissocial/terapia , Pesquisa Comportamental , Transtorno Bipolar/complicações , Transtorno Bipolar/diagnóstico , Transtorno Bipolar/psicologia , Transtorno Bipolar/terapia , Manual Diagnóstico e Estatístico de Transtornos Mentais , Interações Medicamentosas , Feminino , Humanos , Comportamento Impulsivo/diagnóstico , Comportamento Impulsivo/psicologia , Entrevista Psicológica , Masculino , Prontuários Médicos , Modelos Estatísticos , Testes Neuropsicológicos , Determinação da Personalidade , Psicotrópicos/uso terapêutico , Recidiva , Índice de Gravidade de Doença , Transtornos Relacionados ao Uso de Substâncias/complicações , Tentativa de Suicídio/psicologia
3.
J Med Virol ; 62(3): 299-307, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11055239

RESUMO

Hepatitis B virus (HBV) reactivation is a well-described complication in cancer patients who receive cytotoxic chemotherapy and may result in varying degrees of liver damage. As chemotherapy is used increasingly in cancer patients, HBV reactivation during cytotoxic treatment may become a more common problem. In lymphoma patients, the incidence of chronic HBV infection has been reported to be 26%, of whom 47% developed HBV reactivation during chemotherapy. However, corresponding data for patients with other malignancies undergoing cytotoxic chemotherapy are not known. In this prospective study, hepatitis B surface antigen (HBsAg) was determined in 626 consecutive cancer patients who received cytotoxic chemotherapy over a 12-month period. Seventy-eight patients (12%) were found to be HBsAg positive. Thirty-four (44%) developed raised alanine transaminase during their course of chemotherapy. In these 34 patients, hepatitis was attributed to HBV reactivation in 15 patients (44%), chronic active HBV infection in 1 patient (3%), hepatitis C infection in 1 patient (3%), malignant hepatic infiltration in 2 patients (6%), and the use of hepatotoxic chemotherapeutic agents in 11 patients (32%). The causes of hepatitis were unknown in 4 patients (12%). HBV reactivation was more likely to develop in patients who were male, younger age, HBeAg seropositive, and those with lymphoma. Presence of malignant hepatic infiltration, baseline pre-treatment alanine transaminase, total bilirubin, and HBV DNA levels did not correlate with the development of HBV reactivation. Of the 15 patients who developed HBV reactivation, antiviral therapy with lamivudine was available and used in 9. There was no HBV-related mortality during chemotherapy. It is concluded that in patients with chronic HBV infection under chemotherapy, HBV reactivation occurs in nearly 20% of them and accounts for 44% of hepatitis cases. The risk factors identified include male sex, younger age, HBeAg seropositive, and the diagnosis of lymphoma. In HBV endemic areas, patients with risk factors for HBV reactivation should be identified prior to receiving cytotoxic treatment and monitored closely. The potential benefit of lamivudine requires further confirmation.


Assuntos
Vírus da Hepatite B/crescimento & desenvolvimento , Hepatite B/virologia , Imunossupressores/uso terapêutico , Neoplasias/tratamento farmacológico , Adulto , Fatores Etários , Alanina Transaminase/sangue , Feminino , Anticorpos Anti-Hepatite/sangue , Hepatite B/tratamento farmacológico , Hepatite B/epidemiologia , Antígenos de Superfície da Hepatite B/sangue , Antígenos de Superfície da Hepatite B/imunologia , Vírus da Hepatite B/imunologia , Vírus da Hepatite B/isolamento & purificação , Hepatite B Crônica/virologia , Hepatite C/tratamento farmacológico , Hepatite C/epidemiologia , Humanos , Incidência , Lamivudina/uso terapêutico , Neoplasias Hepáticas/epidemiologia , Masculino , Pessoa de Meia-Idade , Neoplasias/complicações , Estudos Prospectivos , Fatores de Risco , Fatores Sexuais , Ativação Viral
4.
J Med Virol ; 60(3): 249-55, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10630955

RESUMO

Reactivation of the hepatitis B virus (HBV) is a rare, but well described complication of cytotoxic chemotherapy that may result in hepatic failure. Patients who are chronic carriers of the HBV and who have a G to A mutation at nucleotide 1896 in the precore region may develop more severe liver disease, possibly because of rapid selection and enhanced replication ability of the mutant strain. Such mutant viruses have been implicated occasionally in chemotherapy induced reactivation of hepatitis B virus. In this report, 5 patients with solid tumours were identified to have developed severe hepatitis B virus related liver disease during treatment with cytotoxic agents (with dexamethasone as anti-emetic). All had clinical and serological evidence of reactivation of the HBV. Three patients developed icteric hepatitis; 2 fully recovered, and 1 had died from progressive metastatic disease while recovering from the reactivation. The other two died from progressive liver failure. Direct sequencing of the polymerase chain reaction (PCR) products of the precore (preC) and precore promoter region of the HBV-DNA was carried out on the patients' serum samples taken during the episode of reactivation. In each case, similar mutations (G to A) in nucleotide 1896 of the preC region were found, together with additional mutations in the preC promoter. The present findings suggest that reactivation involving a mutant hepatitis B virus may lead to liver failure, which is possibly more severe than that caused by wild type HBV, and can be triggered by cytotoxic chemotherapy, or the administration of corticosteroids. In Eastern Asia the HBV carriage rate in adults is high. HBV reactivation and severe liver disease during cytotoxic treatment may become a serious and common problem in this region as cytotoxic chemotherapy is more widely used. Patients should be screened routinely for HBsAg in endemic areas of chronic hepatitis B virus infection prior to receiving cytotoxic treatment. The possibility of HBV reactivation should be considered in patients developing liver dysfunction. Patients who are HBeAg negative/Anti-HBe positive, and are suspected to be having an HBV reactivation, should have HBV-DNA levels measured for confirmation as they may carry a mutant HBV.


Assuntos
Antineoplásicos/efeitos adversos , Neoplasias da Mama/tratamento farmacológico , Carcinoma de Células Pequenas/tratamento farmacológico , Germinoma/tratamento farmacológico , Vírus da Hepatite B/efeitos dos fármacos , Hepatite B/virologia , Adulto , Sequência de Aminoácidos , Antineoplásicos/uso terapêutico , Sequência de Bases , Neoplasias da Mama/complicações , Carcinoma de Células Pequenas/complicações , Análise Mutacional de DNA , DNA Viral/análise , DNA Viral/genética , Feminino , Germinoma/complicações , Vírus da Hepatite B/genética , Vírus da Hepatite B/crescimento & desenvolvimento , Humanos , Lamivudina/uso terapêutico , Masculino , Dados de Sequência Molecular , Mutação de Sentido Incorreto , Regiões Promotoras Genéticas , Inibidores da Transcriptase Reversa/uso terapêutico , Transativadores/genética , Proteínas Virais Reguladoras e Acessórias , Ativação Viral/efeitos dos fármacos
5.
Alcohol Clin Exp Res ; 23(8): 1342-51, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10470977

RESUMO

BACKGROUND: Studying the effects of alcohol on Continuous Performance Test (CPT) performance was of interest for two reasons, i.e., (1) perhaps because of the ease of the task used in previous experiments, alcohol has not been found to impair performance, and (2) CPT commission errors (described below) have been related to impulsive behavior. METHODS: In this study, the CPT featured both an Immediate Memory Task (IMT) and a more difficult Delayed Memory Task (DMT). We compared the performance of 18 subjects under both alcohol and placebo conditions, using a within-subject design. Both the IMT (0.5-sec delay) and the DMT (3.5-sec delay, with distracter stimuli at 0.5-sec intervals) required the subject to respond if a briefly displayed number was identical to the one presented before it. Stimuli included target (identical match), catch (4 of 5 digits matched), and novel (random number) stimuli. On 2 separate days, subjects performed between administrations of three hourly placebo drinks or three hourly drinks containing 0.20 g/kg of alcohol (producing peak breath alcohol concentrations of approximately 0.035%). RESULTS: The main finding was that alcohol consumption increased responses to catch stimuli (i.e., commission errors) in the DMT. In contrast, performance in the IMT (the easier task) was unaffected by alcohol. Commission errors measured during peak breath alcohol concentrations were significantly correlated with scores on the Barratt Impulsivity Scale for both the IMT and DMT. Discriminability (A') between target and catch stimuli was reduced by alcohol for the DMT only. CONCLUSIONS: These data indicate that even small amounts of alcohol can produce measurable changes in CPT performance parameters if the task is of sufficient difficulty and that commission errors can be increased by alcohol consumption.


Assuntos
Depressores do Sistema Nervoso Central/administração & dosagem , Etanol/administração & dosagem , Memória de Curto Prazo/efeitos dos fármacos , Retenção Psicológica/efeitos dos fármacos , Adulto , Testes Respiratórios , Feminino , Humanos , Masculino , Análise e Desempenho de Tarefas
6.
J Med Virol ; 59(3): 263-9, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10502254

RESUMO

Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replication and to improve histology in chronic carriers of hepatitis B virus. The outcome of lamivudine therapy (at doses of 100 or 150 mg/day) in eight patients who developed HBV reactivation while receiving cytotoxic chemotherapy is described. Each of the eight patients had >98% suppression of the pretreatment HBV DNA levels. Three of the five patients who were initially HBeAg positive underwent seroconversion. Five patients had normalization of liver function tests and improvement in clinical condition. However, one patient died of hepatic failure due to HBV-related submassive liver necrosis, and two died of widespread metastases (including liver) from the primary malignancies. It is concluded that early commencement, i.e., at the onset of HBV reactivation before severe hepatic decompensation, of lamivudine may be effective in the control of HBV reactivation during chemotherapy. In Hong Kong, where hepatitis B infection is endemic, we propose to screen all cancer patients for hepatitis B surface antigen before immunosuppressive/cytotoxic therapy, and to closely monitor liver function of those who are found to be HBsAg seropositive.


Assuntos
Antivirais/uso terapêutico , Vírus da Hepatite B/efeitos dos fármacos , Hepatite B Crônica/tratamento farmacológico , Lamivudina/uso terapêutico , Ativação Viral/efeitos dos fármacos , Adulto , DNA Viral/análise , Feminino , Antígenos de Superfície da Hepatite B/imunologia , Antígenos E da Hepatite B/imunologia , Vírus da Hepatite B/crescimento & desenvolvimento , Hepatite B Crônica/imunologia , Hepatite B Crônica/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/complicações , Neoplasias/tratamento farmacológico , Resultado do Tratamento
8.
Psychiatry Res ; 79(3): 255-65, 1998 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-9704872

RESUMO

In an exploratory study, 10 schizophrenic patients and 10 normal control subjects performed immediate and delayed memory tasks, which were variants of previously developed continuous performance tests. Both tasks required participants to identify five-digit numbers which were repeated. Numbers were presented in series for 500 ms each and separated by a 500-ms time-out period. In the immediate memory task, subjects were to respond if a number was identical to the one that had immediately preceded it. The delayed memory task differed from the first task in that a longer delay (3.5 s) between stimuli was introduced, and during this delay distracter stimuli appeared. While normal control subjects performed accurately on both tasks (exceeding 80% correct detections), schizophrenic patients performed poorly, performing worse on the delayed memory task than on the immediate memory task. Rates of commission errors (responses made to similar, but not identical numbers) were nearly equal between groups on the immediate memory task, but on the delayed memory task normal control subjects made relatively more commission errors while schizophrenic patients made fewer commission errors. No differences in response latencies were observed between subject groups or tasks. This paradigm may prove useful in discriminating subtle differences in immediate and delayed memory capability among psychiatric populations and normal control subjects.


Assuntos
Atenção/fisiologia , Transtornos da Memória/etiologia , Memória de Curto Prazo/fisiologia , Reconhecimento Visual de Modelos/fisiologia , Esquizofrenia/complicações , Psicologia do Esquizofrênico , Adulto , Análise de Variância , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Transtornos da Memória/classificação , Testes Neuropsicológicos , Esquizofrenia/classificação , Fatores de Tempo , Volição/fisiologia
9.
Alcohol Clin Exp Res ; 22(9): 1898-902, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9884131

RESUMO

This study compared the effects of alcohol on aggressive responding between subjects with antisocial personality disorder (ASPD) and subjects without ASPD. Eighteen alcohol drinking subjects (10 subjects without ASPD and 8 subjects with ASPD) underwent testing on a laboratory measure of aggression, the Point Subtraction Aggression Paradigm, after consumption of placebo and three doses of alcohol (0.25 g/kg, 0.5 g/kg, and 1.0 g/kg). There was a significant difference in the effect of alcohol on aggressive responding on the Point Subtraction Aggression Paradigm between subjects with ASPD and subjects without ASPD. Subjects with ASPD had a greater increase in aggressive responding after alcohol, compared with non-ASPD subjects. There was no difference between the two groups in the effect of alcohol on monetary-reinforced responding.


Assuntos
Agressão/efeitos dos fármacos , Intoxicação Alcoólica/psicologia , Transtorno da Personalidade Antissocial/psicologia , Etanol/efeitos adversos , Adulto , Agressão/psicologia , Consumo de Bebidas Alcoólicas/efeitos adversos , Consumo de Bebidas Alcoólicas/psicologia , Transtorno da Personalidade Antissocial/diagnóstico , Relação Dose-Resposta a Droga , Humanos , Masculino , Motivação , Violência/psicologia
10.
AIDS Patient Care STDS ; 12(12): 931-7, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11362065

RESUMO

Few programs exist that offer a range of human immunodeficiency virus (HIV) services to multiple populations (i.e., substance abusers, individuals on probation, sex workers and their clients, court-mandated perpetrators of domestic violence) in multiple settings (i.e., courts, methadone maintenance clinics, residential and outpatient substance abuse treatment programs). The purpose of this article is to describe a model mobile HIV program, highlighting its flexibility in providing services to clients who infrequently present to traditional clinic-based testing sites. This mobile HIV program was developed to provide on-site HIV testing and counseling, education, and linkages to primary care services. The implementation of the program begins with training of agency staff, who then provide preliminary orientation with clients regarding HIV testing. Approximately 3 weeks later, the mobile program staff (HIV nurse specialist and HIV counselors) provide standardized group pretest counseling and education. Clients who decide to be tested meet with mobile program staff for individualized risk assessment and specimen collection. Two weeks later, clients meet with mobile program staff to obtain results and receive posttest counseling; risk reduction strategies are reemphasized at that time. Unique to this program is the provision of referrals for a wide range of primary care services for both seropositive and seronegative clients. Since 1994, the mobile program has been implemented at six sites, and over 1100 clients have been served. Two major outcomes from the program have been observed: 1. With adequate preparation and psychological support, 40% of hard-to-reach populations will elect to be HIV tested. 2. Through social networks of program participants, HIV-positive individuals not previously engaged in care have been referred to a comprehensive HIV primary care program.


Assuntos
Aconselhamento , Infecções por HIV/diagnóstico , Infecções por HIV/prevenção & controle , Acessibilidade aos Serviços de Saúde , Unidades Móveis de Saúde , Educação de Pacientes como Assunto , Boston , Humanos , Projetos Piloto
11.
Arch Intern Med ; 157(18): 2076-8, 1997 Oct 13.
Artigo em Inglês | MEDLINE | ID: mdl-9382663

RESUMO

BACKGROUND: While prior studies show that combat veterans with posttraumatic stress disorder (PTSD) report more physical symptoms than veterans without PTSD, the link between PTSD and somatic complaints in Persian Gulf War veterans (PGWVs) is yet to be evaluated. METHODS: A questionnaire booklet was completed by 188 PGWVs, of whom half were patients in a veterans health screening clinic and half were non-treatment-seeking volunteers on active duty. The booklet included the Combat Exposure Scale, the Mississippi Post-Traumatic Stress Disorder Scale (MPTSD), and a subjective symptom-based health questionnaire. RESULTS: The 24 PGWVs (12.8%) with PTSD (MPTSD score > or = 116) reported more combat exposure (P = .02) and a greater number of physical symptoms (P = .001) than other PGWVs. Fatigue, nausea, muscle aches, dizziness, back pain, stomach ache, and numbness were much more likely to be reported by those with PTSD (MPTSD score > or = 116) than by those without PTSD (MPTSD score < or = 95). CONCLUSIONS: Physicians examining PGWVs should be alert to the possibility of PTSD in this group and that those with PTSD are more likely to report physical symptoms that may overlap with those in Persian Gulf syndrome. Consequently, mental health screening is essential, since for those veterans with PTSD diagnosis of other coexisting conditions may be confounded and early effective treatment of their PTSD may be delayed. Also, given the increased reporting of certain symptoms by those with PTSD, those seeking the cause of Persian Gulf syndrome should control for PTSD when determining the symptom cluster that may constitute this condition.


Assuntos
Transtornos Psicofisiológicos/psicologia , Transtornos de Estresse Pós-Traumáticos/psicologia , Veteranos/psicologia , Adulto , Feminino , Humanos , Masculino , Oriente Médio , Razão de Chances , Inquéritos e Questionários , Guerra
12.
Neuropsychopharmacology ; 16(3): 191-201, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9138435

RESUMO

The distribution of drug-free plasma homovanillic acid (pHVA) concentrations was studied in a sample of psychotic patients, some of whom were selected for good prognostic features. Baseline pHVA was bimodally distributed, suggesting two different patient populations. The high-pHVA patients showed periods of better functioning and/or fewer symptoms 5 years before admission (p < .05) and had a more rapid (p < .05) and complete (p < .001) subacute neuroleptic response than lower-pHVA psychotics. High-pHVA psychotics did not differ in other aspects of demographics or clinical presentation from lower-pHVA psychotics. Compared to the general population, there were more psychotics in the families of high-pHVA patients (p < .005). Rapid antipsychotic response by high-pHVA psychotics is consistent with blockade of the effects of excess synaptic dopamine at D2 receptors for these patients. Results are discussed in the context of the syndromic heterogeneity of the psychoses.


Assuntos
Ácido Homovanílico/sangue , Transtornos Psicóticos/etiologia , Adolescente , Adulto , Antipsicóticos/uso terapêutico , Família , Feminino , Haloperidol/uso terapêutico , Humanos , Masculino , Metoxi-Hidroxifenilglicol/sangue , Pessoa de Meia-Idade , Prognóstico , Transtornos Psicóticos/diagnóstico , Transtornos Psicóticos/tratamento farmacológico
13.
Can J Surg ; 39(4): 302-11, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8697321

RESUMO

OBJECTIVE: To examine the combined and individual predictive values of fine-needle aspiration (FNA), physical examination (PE) of the breast and mammography (the "triple test") in diagnosing breast cancer in relation to the results of open surgical biopsy. DESIGN: A study of the records of patients who received both FNA and open surgical biopsy for the same palpable breast lump. The results of diagnostic assessment and open surgical biopsy were categorized as positive or negative. Concordance (percentage of tests found to be correct at biopsy), sensitivity, specificity (percentage of patients without breast cancer for whom the diagnostic test was negative) and positive predictive value (percentage of patients with a positive test found to have breast cancer) were determined for the triple test for each diagnostic modality. In addition, prognostic variables (tumour size, node positivity, estrogen and progesterone receptor status) and outcomes were assessed in patients with a diagnosis of breast cancer. SETTING: A university-affiliated general hospital with a special focus on women's health. PATIENTS: Of 290 patients who had both FNA and open surgical biopsy, 191 underwent all three diagnostic procedures. MAIN OUTCOME MEASURES: The diagnostic accuracy of FNA, PE and mammography to permit preoperative definitive therapy or to allow observation without mandating open surgical biopsy. RESULTS: In 81 patients all three diagnostic modalities were in agreement for a diagnosis of either benign or malignant disease; the concordance for the triple test was 98.8% specificity was 100% and sensitivity was 95.5%. Nodal status, tumour size and outcome were similar whether or not the triple test was positive, but, interestingly, when the triple-test results were positive, estrogen (p < 0.05) and progesterone (p < 0.03) receptor values were more likely to be negative. CONCLUSIONS: When all three diagnostic modalities were in agreement for a diagnosis of malignant disease, the combination of FNA, PE and mammography had excellent concordance with the results of open surgical biopsy, and in this situation definitive treatment may be carried out. If all three modalities are in agreement for a diagnosis of benign disease, a period of close observation with repetition of FNA may be safely entertained. Lack of concordance of the three diagnostic modalities mandates biopsy. Triple-test positively does not predict a worse outcome.


Assuntos
Biópsia por Agulha/normas , Neoplasias da Mama/diagnóstico , Mamografia/normas , Palpação/normas , Adulto , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Cuidados Pré-Operatórios , Prognóstico , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Sensibilidade e Especificidade , Resultado do Tratamento
14.
Schizophr Res ; 19(2-3): 177-87, 1996 May.
Artigo em Inglês | MEDLINE | ID: mdl-8789916

RESUMO

Dynamic 133Xe single photon emission computed tomography (SPECT) was used to measure regional cerebral blood flow (rCBF) during the Wisconsin Card Sorting test (WCS) and the Number Matching task (NM) in six never-medicated first break schizophrenic and schizophreniform patients, seven chronic schizophrenic patients, and seven normal controls. Because of a difference in mean age between first break patients and normals, we adjusted rCBF data for age effects using ANCOVA. For age-adjusted absolute superior and middle frontal rCBF bilaterally, we found significantly less activation from NM to WCS in first break patients compared to normals. Similarly, for age-adjusted absolute and relative left middle frontal rCBF, we found significantly less activation in chronics compared to normals. Changes in age-adjusted global cerebral blood flow (gCBF) were not statistically significant among the three groups, but were in the same direction as activated absolute frontal rCBF. Because of the small number of subjects in each group, the results of this study should be regarded as preliminary and interpreted cautiously.


Assuntos
Atenção/fisiologia , Córtex Cerebral/irrigação sanguínea , Aprendizagem por Discriminação/fisiologia , Resolução de Problemas/fisiologia , Esquizofrenia/diagnóstico por imagem , Psicologia do Esquizofrênico , Tomografia Computadorizada de Emissão de Fóton Único , Adolescente , Adulto , Mapeamento Encefálico , Córtex Cerebral/diagnóstico por imagem , Doença Crônica , Dominância Cerebral/fisiologia , Feminino , Lobo Frontal/irrigação sanguínea , Lobo Frontal/diagnóstico por imagem , Humanos , Processamento de Imagem Assistida por Computador , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Fluxo Sanguíneo Regional/fisiologia , Esquizofrenia/fisiopatologia
15.
Ann Clin Psychiatry ; 7(4): 167-73, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8721890

RESUMO

The goal of this study was to determine if demographic or clinical factors collected at baseline on patients treated with clozapine would increase the risk of having clozapine discontinued for (a) lack of response, (b) side effects, (c) noncompliance, (d) concomitant illness, or (e) death. The subjects were 805 patients treated with clozapine at 96 Department of Veterans Affairs Hospital System facilities. Multiple logistic regression was used to determine if any of the baseline variables predisposed patients to discontinuation from treatment. Factors which were studied include age, race, history of inadequate response to traditional neuroleptics, history of substance abuse, and DSM-III-R Axis I diagnosis. Of the 805 patients started on clozapine 167 (20.7%) were discontinued from treatment. The only significant variable in the logistic regression model was race. This study finds that African American patients are more likely to have clozapine discontinued than non-African American patients, and there is a trend for prior history of inadequate response to traditional neuroleptics to predict clozapine discontinuation. We found no effect of substance abuse or dependence, diagnosis, or age on outcome in the overall patient group. In a post hoc analysis the African American patients had a significantly lower baseline white blood count than the non-African American patients, which could have explained the difference in clozapine discontinuation. The findings of this study support further investigation into the causes of ethnic differences in treatment outcome with clozapine.


Assuntos
Antipsicóticos/uso terapêutico , Clozapina/uso terapêutico , Transtornos Psicóticos/tratamento farmacológico , Esquizofrenia/tratamento farmacológico , Transtornos Relacionados ao Uso de Substâncias/tratamento farmacológico , Adulto , Clozapina/administração & dosagem , Feminino , Hospitalização , Hospitais de Veteranos , Humanos , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Transtornos Psicóticos/reabilitação , Grupos Raciais , Esquizofrenia/reabilitação , Transtornos Relacionados ao Uso de Substâncias/reabilitação
16.
Schizophr Res ; 17(3): 229-40, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8664202

RESUMO

Dynamic 133Xe Single Photon Emission Computed Tomography (SPECT) was used to measure the resting regional cerebral blood flow (rCBF) in 16 neuroleptic free schizophrenic and schizophreniform male patients and 13 age-matched male normal controls. A subgroup consisting of 'first break' patients who had never been exposed to neuroleptic treatment were age-matched to a subgroup of young chronic patients most of whom had been previously exposed to neuroleptics. The age-adjusted rCBF values were compared among first breaks, young chronics, normal controls, and a subgroup of older, more chronic patients. In first break patients, we found significantly lower absolute global cerebral blood flow and significantly lower superior frontal, middle frontal, and middle temporal absolute rCBF compared to normals. We also found significantly lower relative superior frontal rCBF in first breaks vs. normals, and higher relative superior frontal and relative middle frontal rCBF in older chronics vs. the other groups. For relative posterior temporal rCBF there was greater asymmetry (right side > left) in first breaks and young chronics compared to normals and older chronics.


Assuntos
Encéfalo/irrigação sanguínea , Esquizofrenia/diagnóstico por imagem , Psicologia do Esquizofrênico , Tomografia Computadorizada de Emissão de Fóton Único , Doença Aguda , Adulto , Córtex Cerebral/irrigação sanguínea , Doença Crônica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valores de Referência , Fluxo Sanguíneo Regional/fisiologia , Esquizofrenia/fisiopatologia , Radioisótopos de Xenônio
17.
Science ; 268(5213): 1026-9, 1995 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-17774230

RESUMO

Ulysses spacecraft radio and plasma wave observations indicate that some variations in the intensity and occurrence rate of electric and magnetic wave events are functions of heliographic latitude, distance from the sun, and phase of the solar cycle. At high heliographic latitudes, solartype Ill radio emissions did not descend to the local plasma frequency, in contrast to the emission frequencies of some bursts observed in the ecliptic. Short-duration bursts of electrostatic and electromagnetic waves were often found in association with depressions in magnetic field amplitude, known as magnetic holes. Extensive wave activity observed in magnetic clouds may exist because of unusually large electron-ion temperature ratios. The lower number of intense in situ wave events at high latitudes was likely due to the decreased variability of the high- latitude solar wind.

18.
Psychiatry Res ; 61(1): 15-31, 1995 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-7568566

RESUMO

We used 133Xe dynamic single-photon emission computed tomography (DSPECT) to measure the resting cerebellar blood flow in 17 neuroleptic-free schizophrenic and schizophreniform patients and 13 normal control subjects. A subset of these subjects (11 patients and 7 control subjects) additionally underwent activation studies during the Wisconsin Card Sorting (WCS) and Number Matching (NM) tests. Baseline relative cerebellar blood flow was significantly lower in older patients than in age-matched control subjects. For absolute cerebellar flow, there was a significant difference between patients and control subjects in the overall activation response (patients: NM 13.4% increase, WCS 15.7% increase; control subjects: NM 3.1% decrease, WCS 0.0% change). This difference was more pronounced in older subjects. Cerebral blood flow significantly increased during NM (patients: 21.3% increase, control subjects: 6.5% increase) and WCS (patients: 16.5% increase, control subjects: 9.7% increase). The difference in the magnitude of cerebral NM activation between schizophrenic patients and control subjects, although not statistically significant, may call into question the appropriateness of using NM as a control task in schizophrenic patients. Finally, we found no differences between the effects of WCS and NM on cerebellar or cerebral blood flow. Because of the small number of subjects in each group, the results of this study should be interpreted cautiously.


Assuntos
Cerebelo/irrigação sanguínea , Cerebelo/fisiopatologia , Esquizofrenia/fisiopatologia , Adulto , Fatores Etários , Encéfalo/irrigação sanguínea , Encéfalo/diagnóstico por imagem , Encéfalo/fisiopatologia , Encefalopatias/diagnóstico , Encefalopatias/diagnóstico por imagem , Encefalopatias/fisiopatologia , Cerebelo/diagnóstico por imagem , Feminino , Lateralidade Funcional , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Esquizofrenia/diagnóstico , Esquizofrenia/diagnóstico por imagem , Tomografia Computadorizada de Emissão de Fóton Único
19.
Artigo em Inglês | MEDLINE | ID: mdl-7824757

RESUMO

1. 10 male cocaine dependent patients and 10 sex matched controls were administered several behavioral measures of aggression including the Buss-Durkee Hostility Inventory, and The Brown-Goodwin Life History of Aggression. 2. All subjects were also administered a buspirone neuroendocrine challenge as a measure of serotonin function. 3. The cocaine dependent subjects were significantly more aggressive than the controls. 4. There was a significant correlation between the growth hormone response to buspirone and behavioral measures of aggression in the cocaine dependent subjects, but not in the controls. 5. There was no difference in the overall growth hormone response between the controls and cocaine dependent subjects, possibly due to differences in metabolism of buspirone. 6. This study supports a role for serotonin in aggression in cocaine dependent subjects.


Assuntos
Agressão/efeitos dos fármacos , Cocaína , Comportamento Impulsivo/psicologia , Serotonina/fisiologia , Transtornos Relacionados ao Uso de Substâncias/psicologia , Adulto , Buspirona/farmacocinética , Hormônio do Crescimento/sangue , Humanos , Masculino , Escalas de Graduação Psiquiátrica , Método Simples-Cego , Transtornos Relacionados ao Uso de Substâncias/fisiopatologia
20.
Neuropsychopharmacology ; 10(2): 75-83, 1994 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8024675

RESUMO

We administered the serotonin-1a agonist buspirone (0.4 mg/kg orally) as a neuroendocrine challenge agent to a group of male patients with DSM-III-R major depressive disorder (MDD) (n = 13) and a group of male healthy controls (n = 10). The primary hypothesis of the study was that the prolactin response to buspirone would be blunted in the depressed patients. The prolactin response was significantly lower in depressed patients than in controls. There was no significant relationship between placebo corrected-peak prolactin level and severity of depression or suicidality. There was a nonsignificant trend for the melancholic (n = 5) depressed patients to have a lower placebo corrected-peak prolactin level than nonmelancholic depressed patients (n = 8). Our findings support a role for the serotonin-1a receptor in the etiology of MDD, specifically at the postsynaptic site.


Assuntos
Buspirona/farmacologia , Transtorno Depressivo/sangue , Sistemas Neurossecretores/efeitos dos fármacos , Adulto , Análise de Variância , Buspirona/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Prolactina/sangue , Receptores Histamínicos H1/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...